Black race and CA 19-9 nonproduction is associated with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer

被引:0
|
作者
Martos, Mary P.
Dickey, Erin M.
Abdilleh, Kawther
Ahmad, Syed A.
Maithel, Shishir K.
Hammill, Chet W.
Kim, Hong Jin
Abbott, Daniel E.
Kooby, David A.
Parikh, Alexander A.
Hosein, Peter J.
Merchant, Nipun B.
Datta, Jashodeep
Hester, Caitlin A.
机构
关键词
D O I
10.1158/1538-7445.PANCREATIC24-A019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A019
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Black Race and CA 19-9 Nonproduction is Associated with Limited Pathologic Response to Neoadjuvant Chemotherapy in Patients with Localized Pancreatic Cancer
    Martos, Mary P.
    Dickey, Erin M.
    Yanala, Ujwal R.
    Abdilleh, Kawther
    Ogobuiro, Ifeanyichukwu
    Box, Edmond W.
    Ahmad, Syed A.
    Maithel, Shishir K.
    Hammill, Chet W.
    Kim, Hong J.
    Abbott, Daniel E.
    Kooby, David A.
    Parikh, Alexander A.
    Hosein, Peter J.
    Merchant, Nipun B.
    Datta, Jashodeep
    Hester, Caitlin A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S167 - S168
  • [2] Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.
    Martos, Mary P.
    Dickey, Erin M.
    Yanala, Ujwal R.
    Abdilleh, Kawther
    Ogobuiro, Ifeanyichukwu
    Box, Edmond Worley
    Ahmad, Syed A.
    Maithel, Shishir K.
    Hammill, Chet W.
    Kim, Hong Jin Jin
    Abbott, Daniel Erik
    Kooby, David A.
    Parikh, Alexander A.
    Hosein, Peter Joel
    Merchant, Nipun B.
    Datta, Jashodeep
    Hester, Caitlin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 609 - 609
  • [3] CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer
    Ishii, H
    Okada, S
    Sato, T
    Wakasugi, H
    Saisho, H
    Furuse, J
    Ishikawa, O
    Matsuno, S
    Yokoyama, S
    HEPATO-GASTROENTEROLOGY, 1997, 44 (13) : 279 - 283
  • [4] Importance of preoperative CA 19-9 Levels in Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy
    Tsai, S.
    Krepline, A.
    Aldakkak, M.
    Ritch, P. S.
    Erickson, B. A.
    Johnston, F.
    Christians, K. K.
    Evans, D. B.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S21 - S21
  • [5] CA 19-9 Nonproduction Is Associated With Poor Survival After Resection of Pancreatic Adenocarcinoma
    Hayman, Amanda V.
    Stocker, Susan J.
    Baker, Marshall S.
    Bentrem, David J.
    Prinz, Richard A.
    Marsh, Robert de W.
    Talamonti, Mark S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (06): : 550 - 554
  • [6] Serum CA 19-9 Response to Neoadjuvant Therapy is Associated with Outcome in Pancreatic Adenocarcinoma
    Brian A. Boone
    Jennifer Steve
    Mazen S. Zenati
    Melissa E. Hogg
    Aatur D. Singhi
    David L. Bartlett
    Amer H. Zureikat
    Nathan Bahary
    Herbert J. Zeh
    Annals of Surgical Oncology, 2014, 21 : 4351 - 4358
  • [7] Serum CA 19-9 Response to Neoadjuvant Therapy is Associated with Outcome in Pancreatic Adenocarcinoma
    Boone, Brian A.
    Steve, Jennifer
    Zenati, Mazen S.
    Hogg, Melissa E.
    Singhi, Aatur D.
    Bartlett, David L.
    Zureikat, Amer H.
    Bahary, Nathan
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) : 4351 - 4358
  • [8] CA 19-9 level predicts response to GTX chemotherapy in pancreatic cancer.
    Fogelman, DR
    Schreibman, SM
    Fine, RL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 359S - 359S
  • [9] Ca 19-9 Response to Neoadjuvant Therapy Predicts Outcome in Pancreatic Adenocarcinoma
    Boone, B. A.
    Steve, J.
    Zenati, M. S.
    Hogg, M. E.
    Zureikat, A. H.
    Zeh, H. J.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S159 - S159
  • [10] CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy
    Heilbrun, L. K.
    Khanna, A.
    Venkatramanamoorthy, R.
    Shields, A. F.
    Philip, P. A.
    Zalupski, M. M.
    El-Rayes, B. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)